Excited to share my new website! Showcasing my work in liver disease, transplantation, and clinical informatics — where data meets clinical impact. #HepatologyInformatics https://t.co/6rG6Vs6wTO
Fatty pancreas disorder is now defined as a distinct, organ-specific pathological state of excessive intrapancreatic fat that raises the risk of pancreatitis, pancreatic cancer and multiple forms of diabetes, best diagnosed with MRI.
https://t.co/B6p6n5rt5s
Did you know: It can take an average of 17 years for new science to reach routine clinical practice —and many patients commonly receive half of the recommended care.
This gap between research knowledge and applied clinical practice reflects system-level and behavioral barriers that have profound impacts on patient health.
Dissemination and implementation (D&I) research helps narrow this divide and is the subject of a new blog post from Dr. Debra Tucci, director of NIH’s National Institute on Deafness and Other Communication Disorders.
Read the full post ➡️ https://t.co/LHEruQLnJ4
New review on epidemiology of cardiometabolic multiple long-term conditions #MLTC. Diseases including T2D, CVD, CKD and MASLD/MASH are considered a major global health challenge, driven by shared risks like obesity, insulin resistance and social disadvantage.
https://t.co/CjxoSMQ8Do
The tradeoffs of direct access to results through patient portals and patient burdens, makes me think of @jlouissaint89 work in this space for #HCC. Better communication strategies are needed
How should patients learn they have cancer?
Our new study in @JAMANetworkOpen of 2,400+ patients found that 75% prefer clinician delivery over a patient portal—highlighting the trade-off between immediate access to results and clinical guidance.
https://t.co/kxfbJbr1Eg
Congratulations to @VUMChealth resident Zoe Finer for presenting this oral presentation at @ATCMeeting and getting it out in press! Herein we highlight how #AI uses pre-tx imaging biomarkers & clinical features for prediction of major post-tx adverse cardiac events
2026 AHA-ACC-ADA-ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
https://t.co/ided4IdFqx
It's that time of year again when we share some important liver info @blackingastro!! Thanks, to EventPassHero (black-owned event platform)❤️❤️
Please register for this free webinar: Next week, Jun 23 8:30 pm EST & learn how to exercise for liver health https://t.co/lw5kZba4ZO
Yesterday, the JAMA Network Open Editorial Board met to discuss plans for the journal, which is dedicated to improving health care and advancing health equity worldwide through the open-access dissemination of research across all health disciplines.
Patients responded to automated health care texts with appointment requests, data corrections, and help needs—not just opt-outs—highlighting gaps in current system design and communication.
https://t.co/fMJkEuLOwv
📜 TIPS for refractory hepatic hydrothorax — multicenter European cohort
🗣️ C. Alessandria | #EASLCongress
🔬 Complete response (CR) in 60% → ↑ survival
⚠️ No variable predicted CR — still hard to select the right patient
🩺 TIPS: a valuable option for refractory hydrothorax
Curious about how Large Language Models can support hepatology practice and education? 🤔
Join this Skills Learning Centre session at #EASLCongress 2026!
Build your own Hepatology Chatbot: Foundations of Large Language Models and Applications on EASL Guidelines 🤖
📍 Friday 29 May
🕧 12:30–13:30 CEST
🕑 14:00–15:00 CEST
📌 Skills Learning Centre 5, Hall 7
Enroll here: https://t.co/PZz5f568PY
⚠️ Seats are limited to 20 participants per session, and attendees are encouraged to prepare in advance to fully take part.
@EASLNews@tom_luedde@SaSi_Lens@jnkath@C_V_Schneider@AshleySpannMD@m_giuffre
#EASLCongress
Take a look at our new paper in @JAMANetworkOpen, introducing prediction model for short- and long-term patient mortality after kidney transplantation.
It enables a personalized assessment of post-transplant risk to guide patient follow-up and optimize clinical decision-making.
Excited to share that the Lancet Commission report is now out in press! Incredibly honored to have contributed to this impressive body of work, and the opportunity to highlight how #AI can help us better address the burden of liver disease @EASLnews
@TheLancet@EASLnews second Liver Commission report is online. What a tremendous team effort. A roadmap for health, far beyond that pertaining to liver disease. https://t.co/BmbXpfp9Pv
Landmark prospective study led by our team @MASLDResearch Suzanne Sharpton @LuisAntonioDiaz and a global collaborative team @DrHuangDQ@AASLDtweets@EASLnews
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library https://t.co/ygEgF8SpRX
📢Anyone caring for patients with alcohol-associated liver disease!
This one-pager summarizes the @AASLDtweets guideline on ALD.
It is a must-have for all residents, hospitalists, and GI Fellows! @LiverFellow@geneyim#MedEd